Of the three types of bladder cancer, Non-Muscle Invasive Bladder Cancer (NMIBC) is the most common form and is diagnosed in over 70% of cases. This issue of the Urologic Clinics focuses on NMIBC and includes articles on periopertive chemotherapy, office fulguration, TURBT, surveillance strategies, and radiation therapy in type-1 tumors.
Castrate Resistant Prostate Cancer is advanced disease that has stopped responding to hormone therapy. This issue of the Urologic Clinics focuses on the various forms of therapy including immunotherapy, first line chemotherapy, and novel targeted agents. Articles on defining the diseae and palliative care are also included.
This issue of the Urologic Clinics covers office-based procedures in urology. There are a wealth of urologic procedures that can be done in the office setting, offering reduced risks to the patient, less stress, and better recovery time, as well as a more favourable reimbursement for the physician. Articles include more common issues such as stone management, ultrasound/prostate biopsy, and vasectomy, as well as infusion therapy, biofeedback, and office anesthesia.
The fastest evolving field in urology is certainly male reproductive medicine and surgery. Getting sperm and egg together is beyond what science fiction could have imagined only a few decades ago. Such remarkable progress created a whole host of issues including epidemiologic, surgical, medical, and societal. The authors contributing to this issue were asked to consider their topics today and a couple of decades into the future. As the foundations of reproductive genetics and the male endocrine system undergird all, they are explored in depth. Common conditions such as infection and inflammation, the ever problematic varicocele, and ejaculatory dysfunction are thoughtfully reviewed. The key to the modern management of male infertility, the evaluation and treatment of azoospermia whether it is due to obstruction or spermatogenic dysfunction, is discussed in detail. For the practicing urologist, the nuts and bolts of the infertility office visit, semen analysis and processing, and contraception are reviewed. With increasing public interest, nutraceuticals, lifestyle, and the environment's impact on male reproductive health are examined. And to put male reproductive dysfunction and its treatment in the broadest context, male reproductive epidemiology and reproductive health care delivery are explored. All of these topics are covered by leaders in male reproductive medical thought and practice.
This issue of the Urologic Clinics covers stricture, renal injuries, priapism, penile fractures, and bladder injuries. An article covering necessary plastic surgery principles for the urologist is also included. Dr. Allen Morey serves as Guest Editor of this issue on urologic trauma and reconstruction. Dr. Morey has extensive clinical experience in reconstructive urology with emphasis in urethral stricture disease, and urologic trauma.
This issue of the Urologic Clinics is unique in that it examines the Controversies in Female Pelvic Reconstruction from both the urology and urogynecology standpoint. Areas of controversy regarding evaluation and therapy for a number of conditions unique to women's health are examined. Topics covered include urethral bulking, robotic/laparoscopic prolapse repair, management of bladder pain syndromes, and urodynamics.
The past decade has been marked by the acceleration of our understanding of the molecular biology of cancer. Simultaneously, there have been increasing exigencies to diagnose, treat and follow cancer patients more economically. Biomarkers represent the marriage of science and economics. Biomarkers offer the potential to increase the precision of diagnosis, prognosis, and surveillance of urological malignancies. This issue presents the cutting-edge advances of biomarker technology to urologic oncology.
The Guest Editors have assembled top key opinion leaders to provide current reviews on the multidisciplinary approach to the management of high-grade bladder cancer. Articles are devoted to fluorescence cystoscopy, confocal laser endomicroscopy, narrow band imaging; Novel therapeutic approaches for recurrent nonmuscle invasive bladder cancer; Trimodality therapy in bladder cancer; the data and the reality of perioperative chemotherapy in muscle invasive bladder cancer; radical transurethral resection alone, robotic or partial cystectomy or extended lymphadenectomy: Neoadjuvant paradigm for drug development in muscle invasive bladder cancer; Novel biomarkers to predict response and prognosis in localized bladder cancer; Immunotherapy in Advanced/Metastatic Urothelial Cancer ; and Adjuvant Chemotherapy in High Grade Upper Tract Urothelial Cancer.
In this issue of Urologic Clinics of North America, guest editor Dr. Andrew J. Hung brings his considerable expertise to the topic of Artificial Intelligence in Urology. Alongside technological advancements in artificial intelligence (AI), applications of AI in urology have grown tremendously over the last few years. This special issue highlights areas of particular interest, such as radiomics, pathomics, genomics, and surgery. Top experts in the field cover the current status and also preview future applications, aimed at improved patient outcomes. - Contains 13 relevant, practice-oriented topics including radiomics, pathomics, and surgical AI; genomics and AI: prostate cancer and renal cell carcinoma; pediatric urology and AI; bladder cancer and AI; AI in urology: big data sets; and more. - Provides in-depth clinical reviews on artificial intelligence in urology, offering actionable insights for clinical practice. - Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
In this issue of Urologic Clinics of North America, guest editor Dr. Adam Feldman brings his considerable expertise to the topic of Biomarkers in Urology. The use of biomarkers in clinical practice can range from screening, to refined detection in an at-risk population, to risk stratification following diagnosis, to prognostication following therapy. A better understanding of tumor biology and genetic heterogeneity will lead clinicians to adopt clinical paradigms that utilize sequences of biomarker assessments. In this issue, key experts help you remain at the forefront of the care of urologic malignancies by providing a timely update on emerging biomarkers in urology. - Contains 15 practice-oriented topics including biomarkers in pediatric urology; unleashing the urinary microbiome in benign urologic disease; biomarkers for detection and assessment of clinically significant prostate cancer; biomarkers in testicular cancer: classic tumor markers and beyond; and more. - Provides in-depth clinical reviews on biomarkers in urology, offering actionable insights for clinical practice. - Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
